Viewing Study NCT02776969


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2026-02-22 @ 9:38 AM
Study NCT ID: NCT02776969
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-03
First Post: 2016-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Gene Hunting Study for Familial Papillary Thyroid Cancer
Sponsor: Ohio State University Comprehensive Cancer Center
Organization:

Study Overview

Official Title: A Strategy to Search for Genes Predisposing to Papillary Carcinoma of the Thyroid When Mutated
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2025-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this project is to identify genetic risk factors associated with familial papillary thyroid carcinoma (PTC). Papillary thyroid cancer is a type of cancer that shows high heritability. However, the specific genetic factors that cause an increased risk have been elusive.
Detailed Description: The aim of this project is to identify genetic risk factors associated with familial papillary thyroid carcinoma (PTC). This can be accomplished in several ways, including loss of heterozygosity studies as well as comparative gene expression analysis. When possible, linkage analysis on families with multiple individuals affected with PTC may also help identify the putative gene(s).

Study participants will be asked to:

1. Complete family history and medical history questionnaires
2. Sign a medical record release so that thyroid cancer pathology reports can be obtained
3. Supply a blood or saliva sample for genetic studies
4. Provide study related information to family members who are needed for family studies

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: